xIPOmeter
Resilience
Resilience is engaged in the manufacturing of cell and gene therapies, vaccines, biologics, and nucleic acids. Resilience partners with other firms in order to help them develop and scale their products.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
News related to Resilience2
ResilienceResilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
"Securing this manufacturing program for Resilience is a good step forward for the U.S. pharmaceutical ...
https://finance.yahoo.com/news/resilience-secures-funding-expand-domestic-154300082.htmlResilienceAs US plots biomanufacturing boost, National Resilience nets $410M loan from Defense Department
Resilience will channel the cash toward its goal of building biomanufacturing capacity and capabilities on U.S. soil ...
https://www.fiercepharma.com/manufacturing/white-house-eyes-biomanufacturing-boost-local-producer-national-resilience-adds-410m
Investors6
Lux Capital
GV
8VC
New Enterprise Associates
ARCH Venture Partners
Mubadala Investment Company